D-dimer: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Robert Badgett |
||
| Line 24: | Line 24: | ||
An abnormal D-dimer level at the end of treatment might signal the need for continued [[anticoagulation]] with [[warfarin]] among patients with [[embolism and thrombosis]] such as a first unprovoked [[pulmonary embolism]]. If the D-dimer is abnormal, anticoaguation should be continued, if the D-dimer is normal, the duration of treatment is uncertain.<ref name="pmid17065639">{{cite journal |author=Palareti G, Cosmi B, Legnani C, ''et al'' |title=D-dimer testing to determine the duration of anticoagulation therapy |journal=N. Engl. J. Med. |volume=355 |issue=17 |pages=1780-9 |year=2006 |pmid=17065639 |doi=10.1056/NEJMoa054444}}</ref> In an observation study that collected the D-dimer before stopping anticoagulation, the D-dimer was not as predictive.<ref>Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. [http://www.cmaj.ca/cgi/content/full/179/5/417 Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy]. CMAJ. 2008 Aug 26;179(5):417-426.</ref> | An abnormal D-dimer level at the end of treatment might signal the need for continued [[anticoagulation]] with [[warfarin]] among patients with [[embolism and thrombosis]] such as a first unprovoked [[pulmonary embolism]]. If the D-dimer is abnormal, anticoaguation should be continued, if the D-dimer is normal, the duration of treatment is uncertain.<ref name="pmid17065639">{{cite journal |author=Palareti G, Cosmi B, Legnani C, ''et al'' |title=D-dimer testing to determine the duration of anticoagulation therapy |journal=N. Engl. J. Med. |volume=355 |issue=17 |pages=1780-9 |year=2006 |pmid=17065639 |doi=10.1056/NEJMoa054444}}</ref> In an observation study that collected the D-dimer before stopping anticoagulation, the D-dimer was not as predictive.<ref>Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. [http://www.cmaj.ca/cgi/content/full/179/5/417 Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy]. CMAJ. 2008 Aug 26;179(5):417-426.</ref> | ||
== | ==Diagnosis deep venous thrombosis== | ||
Especially in [[emergency medicine]], it is both fast and economical to use D-dimer to rule out deep venous thrombosis, without going directly to the more time-consuming and expensive [[Doppler ultrasonography]]. " | Especially in [[emergency medicine]], it is both fast and economical to use D-dimer to rule out deep venous thrombosis, without going directly to the more time-consuming and expensive [[Doppler ultrasonography]]."Deep-vein thrombosis can be ruled out in a patient who is judged clinically unlikely to have deep-vein thrombosis and who has a negative D-dimer test" according to a [[randomized controlled trial]]. <ref name="pmid14507948">{{cite journal| author=Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J et al.| title=Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. | journal=N Engl J Med | year= 2003 | volume= 349 | issue= 13 | pages= 1227-35 | pmid=14507948 | doi=10.1056/NEJMoa023153 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14507948 }} [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15122830 Review in: ACP J Club. 2004 May-Jun;140(3):67] </ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 07:56, 11 June 2012
In medicine, D-dimer is a fibrin degradation product after coagulation. It may be elevated in patients with pulmonary embolism or deep venous thrombosis.
Immunologic tests for d-dimer are generally use immunoassays such as enzyme-linked immunosorbent assay or serologic tests such as agglutination tests. The immunoassays (more specifically, enzyme-linked immunosorbent assay) tend to be more sensitive.[1]
In interpretation of the d-dimer, for patients over age 50 a value of ageX10 may be abnormal.[2][3]
| sensitivity | specificity | |
|---|---|---|
| Immunoassays | ||
| Elisa such as VIDAS™ | 95%[1] 96%[4] |
44%[1] 39%[4] |
| Agglutination tests | ||
| Latex agglutination such as Tinaquant™ | 89%[1] 96%[4] |
45%[1] 43%[4] |
| Whole blood hemagglutination test such as SimpliRED™ | 78%[1] 87%[4] |
74%[1] 66%[4] |
Using D-dimer to determine duration of anticoagulation treatment
An abnormal D-dimer level at the end of treatment might signal the need for continued anticoagulation with warfarin among patients with embolism and thrombosis such as a first unprovoked pulmonary embolism. If the D-dimer is abnormal, anticoaguation should be continued, if the D-dimer is normal, the duration of treatment is uncertain.[5] In an observation study that collected the D-dimer before stopping anticoagulation, the D-dimer was not as predictive.[6]
Diagnosis deep venous thrombosis
Especially in emergency medicine, it is both fast and economical to use D-dimer to rule out deep venous thrombosis, without going directly to the more time-consuming and expensive Doppler ultrasonography."Deep-vein thrombosis can be ruled out in a patient who is judged clinically unlikely to have deep-vein thrombosis and who has a negative D-dimer test" according to a randomized controlled trial. [7]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Stein PD, Hull RD, Patel KC, et al. (April 2004). "D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review". Ann. Intern. Med. 140 (8): 589–602. PMID 15096330. [e]
- ↑ van Es J, Mos I, Douma R, Erkens P, Durian M, Nizet T et al. (2012). "The combination of four different clinical decision rules and an age-adjusted D-dimer cut-off increases the number of patients in whom acute pulmonary embolism can safely be excluded.". Thromb Haemost 107 (1): 167-71. DOI:10.1160/TH11-08-0587. PMID 22072293. Research Blogging.
- ↑ Douma RA, le Gal G, Söhne M, Righini M, Kamphuisen PW, Perrier A et al. (2010). "Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts.". BMJ 340: c1475. DOI:10.1136/bmj.c1475. PMID 20354012. Research Blogging.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Di Nisio M, Squizzato A, Rutjes AW, Büller HR, Zwinderman AH, Bossuyt PM (February 2007). "Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review". J. Thromb. Haemost. 5 (2): 296–304. DOI:10.1111/j.1538-7836.2007.02328.x. PMID 17155963. Research Blogging.
- ↑ Palareti G, Cosmi B, Legnani C, et al (2006). "D-dimer testing to determine the duration of anticoagulation therapy". N. Engl. J. Med. 355 (17): 1780-9. DOI:10.1056/NEJMoa054444. PMID 17065639. Research Blogging.
- ↑ Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008 Aug 26;179(5):417-426.
- ↑ Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J et al. (2003). "Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.". N Engl J Med 349 (13): 1227-35. DOI:10.1056/NEJMoa023153. PMID 14507948. Research Blogging. Review in: ACP J Club. 2004 May-Jun;140(3):67